The company has shown remarkable growth, posting a three-year CAGR of around 75% with an ARR of roughly Rs 100 crore and impressive gross margins
Angelini Ventures has already invested €125 million in 22 startups
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
At least one recognised startup in every State and UT; spread across over 80% of districts
Robots make it to the healthcare conference panel, reflecting the future potential of technology
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
Debut Biotechnology has outstanding enzyme search and design technology and a bio-manufacturing platform (precision fermentation, cell-free synthesis) using those enzymes
Pheezee is designed to assess musculoskeletal and neuromuscular health.
The company offers a wide portfolio of services including integrated doctor-led prescription e-commerce enablement, digital health record management, and smart clinics.
Subscribe To Our Newsletter & Stay Updated
